Research Center Profile:
Advanced Pharma CR
Cardiology/Vascular Diseases
Dermatology
Devices
Endocrinology
Family Medicine
Gastroenterology
Healthy Volunteers
Hepatology (Liver, Pancreatic, Gall Bladder)
Internal Medicine
Nephrology
Neurology
Nutrition and Weight Loss
Oncology
Pediatrics/Neonatology
Podiatry
Psychiatry/Psychology
Rheumatology
Urology
Vaccines
"First in Man to Market"
Advanced Pharma CR (APCR) is a dedicated Phase I Clinical Research Facility. We are located within the City of Miami’s Health District, the second largest in the nation, in the architecturally “green” University of Miami Life Science and Technology Park. Our location bolsters our relationships with many specialists and subspecialists and serves as a magnet for attracting a high volume of volunteers, while providing a state-of-the-art facility for pharmaceutical, biotech, and medical device industries.
APCR provides pharmaceutical, biotech, and medical device companies with a state-of-the-art, 25,000 square feet facility that houses 150 beds, which includes two (16 bed and 24 bed) Intensive Procedure Units (IPUs).
APCR’s principals have participated in Phase I clinical trials since 1992. Advanced Pharma’s Executive Medical Director Dr. Gilbert R. Weiner, DO, AOBFP, CPI is board certified in Family Practice and has been practicing medicine since 1967. As a Certified Physician Investigator, Dr. Weiner has participated in over 500 Phase I clinical trials. Dr. Weiner and the rest of our team have 50-plus years of combined research experience in over 1,000 Phase I trials. Our multi-specialty physician investigators enable APCR to engage in multiple aspects of Phase I pharmaceutical, biotech, and medical device trials.
Our historical volunteer data confirms that we have outstanding recruitment, enrollment, and retention statistics. We retain a robust database of over 10,000 volunteers. APCR exceeds industry standards for enrollment requirements and trial completion percentages.
Phase I Trial Experience: Healthy Volunteers
Bioavailability/Bioequivalence (BA/BE)
Ascending Dose
Absorption Distribution Metabolism & Excretion (ADME)
QT/QTc Safety
PK/PD
Food Effect (Fed/Fasted)
Vaccines
Drug-to-Drug Interaction
Maximum Tolerated Dose
Drug Transfer
Single/Multiple Dose
Patch Testing
Devices
Phase I Trial Experience: Special Populations
Hepatic Impairment
Hepatic impairment, including, but not limited to, Hepatitis A, B, and C
Hepatic classifications as Child-Pugh A, Child-Pugh B, and Child-Pugh C (mild, moderate, and severe)
Renal Insufficiency
Classification as Mild, Moderate, and Severe, including Dialysis
Type II Diabetes
Elderly
Hypertension
Pre/Postmenopausal
Obesity
Route Administration Experience
Intrathecal
Rectal
Vaginal
IV Infusion
IV Push
Injection: IM and Sub-Q
Topical
Oral
Sublingual
In addition to the Phase I experience listed above, we serve ALL Specialties and ALL Indications.
Late Phase Development
Phases II-IV
Clinical Research Experience
Gastroenterology: GERD, Crohn’s Disease, Ulcerative Colitis, Irritable Bowel Syndrome with Diarrhea/Constipation, Gastritis; Hepatic Impairment: Hepatitis A, B and C, Hepatic Cirrhosis
Nephrology: Renal Insufficiency (mild, moderate, severe, including Dialysis), Chronic Kidney Disease
Cardiology: Hypertension, Acute Coronary Syndrome, Chronic Heart Failure, Atrial Fibrillation, Hyperlipidemia
Dermatology: Psoriasis, Eczema, Dermatitis, Discoid Lupus Erythematosus
Endocrinology: Diabetes (Type I & Type II), Hypo- & Hyperthyroidism, Cushing’s Syndrome, Acromegaly
Internal Medicine: Geriatric, Obesity, Weight Loss & Dietary Assistance, Smoking Cessation
Medical Device: Orthotics for Diabetic Foot Ulcers, Diabetic Neuropathy, Plantar Fasciitis
Neurology: Epilepsy
Oncology/Hematology: Iron Deficiency Anemia, Lung Cancer, Breast Cancer, Bone Cancers, Uterine Cancer
Pain Management: Opioid Induced Constipation (OIC), Low Back Pain, Intractable Pain
Podiatry: Plantar Fasciitis, Bunions, Ingrown Nails, Nail Fungus
Pulmonology: Emphysema, COPD, Asthma
Psychiatry: Depression, MDD, Schizophrenia, Anxiety, Cognitive Disorders
Rheumatology: Arthritis, Lupus, Systemic Lupus Erythematosus
Urology: Urinary Tract Infection, Acute Pyelonephritis
Vaccines: Measles, Mumps, and Rubella (MMR), Flu, Human Papillomavirus
Women’s Health: Uterine Fibroid, Hormone Replacement Therapy (HRT), Osteoporosis, Postmenopausal
Throughout the years, our experienced research team has participated in clinical trials working directly with the following Sponsors/CRO's:
Wyeth
GSK
Berlex Laboratories
Sanofi
Kos Pharmaceuticals
Roche
Solvay
Dow Pharmaceuticals
Pfizer
PPD
Forest Laboratories
Johnson & Johnson
Genzyme
Aventis
Salix Pharmaceuticals
Gilead
Astra Zeneca
Ivax
Merck
BioSante Pharmaceuticals
Janssen
Abbott
Organon Pharmaceuticals
TAP Pharmaceuticals
Allergan
ICI Pharmaceuticals
MedImmune
Bristol Myers Squibb
Ayerst Laboratories
Ortho McNeil
Otsuka Pharmaceutical
Schering Plough Research Institute
Galderma
Novo-Nordisk
Sepracor
Genetech
K-Force CRO
Mylan
Teva
Cetero
Yamanouchi
Watson
Amgen
Theravance
AMAG Pharmaceuticals
Our current operations include a 25 bed dedicated Phase I Unit. Expansion to 25,000 square feet is underway. Upon completion of the build-out in November 2012, we will house 150 beds, which will include two (16 bed and 24 bed) Intensive Procedure Units (IPUs).
Clinical Trial Services
Advanced Pharma includes the following departments, each with its own dedicated staff of skilled, appropriately trained and certified professionals.
Contracts and Budgeting
Regulatory Affairs
Recruitment & Retention
Clinical Coordinating
Training (Study/Protocol Specific)
Facility Operations
Source Document Creation & Implementation
Clinical Laboratory
Data Management
Pharmacy
Information Technology
Quality Assurance/Quality Control
Phase I Business Development
Phase II-IV Business Development
Marketing & Advertising
Our facility has the following areas and features:
Secured, Dedicated Pharmacy
Secured, Dedicated Laboratory
Secured, Dedicated Record Room
Physical Examination Areas
Dosing and Procedure Room
Recliner Equipped Dosing Area
Observation Sleep Areas
Screening/Waiting Rooms
Recreation Room
Secured Server Room
Fully Generator Equipped for 24-7, 365 days of uptime
Dedicated Offices
Dedicated Reception Areas
Dedicated Monitoring Room with Phone and Internet Access
Security Cameras throughout Facility
Building Alarm System
Synchronized Study Clocks
Green-Friendly
APCR Principals
Samantha Amaba
President & CEO
samaba@advancedpharmacr.com
Samantha Amaba began participating in research in 1992, when she took part in Cardiology Device Research at a large teaching hospital in Memphis, TN. After acquiring a wealth of research experience, Samantha relocated to South Florida where she became involved in Pharmaceutical Research, in particular managing Phase I-IV Clinical Trials. She has substantial management experience in Special Populations as well. Samantha has demonstrated exceptional ability to direct multiple million-dollar trials with complete satisfaction from clients.
Through the years, Samantha has maintained an excellent relationship and reputation within the pharmaceutical industry. Her passion for Clinical Research has proven to be the avenue to her success!
Ivette Lopez, CCRC
Vice President & COO
ilopez@advancedpharmacr.com
Key Members of APCR
Medical Staff
Gilbert Weiner, DO, AOBFP, CPI
Medical Director - Principal Investigator
Terrye Thomas, RPh
Associate Director, Pharmacy
tthomas@advancedpharmacr.com
Operational Staff
Sylvia Corrrea
Office Manager
scorrea@advancedpharmacr.com
Advanced Pharma CR uses a local/central IRB, Independent IRB, and we are also willing to work with an IRB of your choosing.
If you are interested in contacting this center to discuss placing a clinical
trial there, please complete and send the email form below. A representative from
the research center will then follow up with you.